Live Quote · NASDAQTBPHHealthcare· Biotechnology

Theravance Biopharma Inc

$17.03▲ 0.00%(+$0.00)
MKT CAP $884.18MLAST EARNINGS Nov 10, 2026
50%
Bullish
TickerSpark Score
81/100
▌ Strong
80
Valuation
100
Profitability
100
Growth
76
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TBPH research report →

Analyst Price Target
$17.00-0.2% vs. today

Range $17 – $17

Analyst RatingHold
4 Buy10 Hold3 Sell

Price Chart

+23.50% · this period
$20.74$17.16$13.57Sep 25Mar 27Sep 25
52-Week Range50% of range
Low
$13.08
Current
$17.03
High
$21.03